Show simple item record

dc.contributor.authorLafuente Merchán, Markel
dc.contributor.authorRuiz Alonso, Sandra
dc.contributor.authorGarcía Villén, Fátima
dc.contributor.authorGallego Garrido, Idoia
dc.contributor.authorGálvez Martín, Patricia
dc.contributor.authorSáenz del Burgo Martínez, Laura ORCID
dc.contributor.authorPedraz Muñoz, José Luis ORCID
dc.date.accessioned2022-08-31T08:30:38Z
dc.date.available2022-08-31T08:30:38Z
dc.date.issued2022-07-29
dc.identifier.citationPharmaceutics 14(8) : (2022) // Article ID 1578es_ES
dc.identifier.issn1999-4923
dc.identifier.urihttp://hdl.handle.net/10810/57367
dc.description.abstractOsteochondral injuries can lead to osteoarthritis (OA). OA is characterized by the progressive degradation of the cartilage tissue together with bone tissue turnover. Consequently, joint pain, inflammation, and stiffness are common, with joint immobility and dysfunction being the most severe symptoms. The increase in the age of the population, along with the increase in risk factors such as obesity, has led OA to the forefront of disabling diseases. In addition, it not only has an increasing prevalence, but is also an economic burden for health systems. Current treatments are focused on relieving pain and inflammation, but they become ineffective as the disease progresses. Therefore, new therapeutic approaches, such as tissue engineering and 3D bioprinting, have emerged. In this review, the advantages of using 3D bioprinting techniques for osteochondral regeneration are described. Furthermore, the biomaterials, cell types, and active molecules that are commonly used for these purposes are indicated. Finally, the most recent promising results for the regeneration of cartilage, bone, and/or the osteochondral unit through 3D bioprinting technologies are considered, as this could be a feasible therapeutic approach to the treatment of OA.es_ES
dc.description.sponsorshipThis research was funded by the BASQUE COUNTRY GOVERNMENT/EUSKO JAURLARITZA (Department of Education, University and Research, Consolidated Groups IT907- 16). Author S.R.-A. thank the BASQUE COUNTRY GOVERNMENT for the granted fellowship (PRE_2021_2_0153).es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject3D bioprintinges_ES
dc.subjectosteoarthritises_ES
dc.subjecttissue engineeringes_ES
dc.subjectregenerative medicinees_ES
dc.subjectcartilagees_ES
dc.subjectbonees_ES
dc.titleProgress in 3D Bioprinting Technology for Osteochondral Regenerationes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.date.updated2022-08-25T11:19:14Z
dc.rights.holder© 2022 by the authors.Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).es_ES
dc.relation.publisherversionhttps://www.mdpi.com/1999-4923/14/8/1578es_ES
dc.identifier.doi10.3390/pharmaceutics14081578
dc.departamentoesFarmacia y ciencias de los alimentos
dc.departamentoeuFarmazia eta elikagaien zientziak


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

© 2022 by the authors.Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).
Except where otherwise noted, this item's license is described as © 2022 by the authors.Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).